Noha Gaber
T1 DM & Pregnancy; Double Trouble
Iman Youssef
2021 ESC Guidelines for diagnosis and treatment of Dyslipidemia
Ahdy Helmy
Novel Lipid Lowering means, from antibodies to genes silencing
Megahd Abou El Magd Hyperprolactinemia Clinical Cases
Mesbah Kamel
Andropause
Talaat Abdel Aaty
Basal insulin + GLP1 RA Fixed Ratio Combination advantages in
Ahmed Zeid | NAFLD in DM who to screen and how to screen
Nabil El Naggar
B The origin and evolution of Diabetic vasculopathy
Mohamed Abdel Raouf Dapagliflozin – The care that all T2D patients deserve
Talaat Abdel Aaty
Dapagliflozin & what's New
Mohamed Zaitoun
iDegLira the power of DUAL action
Hossam Ghazi
Advancing Basal Insulin therapy in the Solimix trial
Mohamed Zaitoun
Real life evidence of Vildagliptin in T2DM Management
Talaat Abdel Aaty
Nabil El Kafrawy
Step One in Diabetes Management
Fawzy El Mosalamy & Mohamed Zaitoun
Questions yet to be answered in Diabetes
Aly Abdel Raheem
Questions yet to be answered in Diabetes
Mohamed Zaitoun & Kamel Hamida
When does Glycemic control mandate primary prevention?
Ibrahim El Ebrashy
Second generation basal insulin; Innovation to fulfill needed benefits
Samir Helmy Assaad
Diabetes: Beyond Numbers, Chemistry and Pharmaco- Therapy
Ibrahim El Ebrashy
Management of Type 2 Diabetes beyond glycemic control
Samir Naim Assaad | Hormonal Control of Appetite From Basics to Clinical Practice
Samir Naim Assaad | Hormonal Control of Appetite From Basics to Clinical Practice
Alaa Wafa
Thyroid and pituitary cross talk
Khaled El Hadidy
Noha Gaber
Sherif Bayoumy
A case of type1 DM & autoimmune diseases
Nourhan yousry
A case of type1 DM&autoimmune diseases
Mohamed Noah
Approach to manage a case J adrenal Incidentaloma
Hend Abdel Moneim
Hypoglycemia
Mai Badrah
Gut microbiota
Shimaa Zewain
Primary hyper parathyroid
Amr El Fiky
Obesity An underestimated risk for cancer
Kamel Hameda
Standing on the SGLT2 inhibitors’ shore Helping you protect the core
Mario Skugor Recent and updated management of obesity
Mario Skugor